About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1192 record(s)
Req # A-2023-000832
The number of people employed by your department who have had contract service recognized since 1989 and any employment benefits they may have received, indicating the years of service, monetary value of benefits and the financial authority under…Organization: Health Canada
March 2024
Req # A-2023-001002
The month and year that the Rupatadine Abbreviated New Drug Submission (ANDS) was accepted into review; and the status of the ANDS review for the Rupatadine ANDS.Organization: Health Canada
March 2024
Req # A-2023-001004
Please advise whether the Rupatadine Abbreviated New Drug Submission (ANDS) has received either: a Screening Acceptance Letter; a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W); or a NON-Withdrawal (NON-W).Organization: Health Canada
March 2024
Req # A-2023-001020
All records relating to the determinations that: The active ingredient of Teva-Teriparatide Injection is classified as a pharmaceutical drug substance rather than a biologic. In vivo bioequivalence studies were not required for the Teva-Teriparatide…Organization: Health Canada
March 2024
Req # A-2023-001055
All records generated in the process of responding to/fulfilling Access to Information and Privacy (ATIP) request A-2022-001233. Exclude records already disclosed in the response package for A-2022-001233.Organization: Health Canada
March 2024
Req # A-2023-001075
Reports, presentations, studies, or draft reports completed by the Public Service Occupational Health Program regarding vibration exposure onboard rigid hull inflatable boats, completed for any department between January 2015 to November 2023.Organization: Health Canada
March 2024
Req # A-2023-001111
All e-mail exchanges between Health Canada and Epoch Times Canada starting April 2023 to November 28, 2023 regarding questions and responses to those questions which address the plasmid contamination, genomic integration, Simian Virus 40 (SV40),…Organization: Health Canada
March 2024
Req # A-2023-001112
Email exchange between Health Canada and Matthew Horwood and/or Noe Chartier from Epoch Times Canada starting July 2023 to November 28, 2023 regarding questions and responses to those questions which address the plasmid contamination, genomic…Organization: Health Canada
March 2024
Req # A-2023-001122
With respect to the Pfizer report entitled 125742 S1 M2 24 nonclinical-overview, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks of the vaccine…Organization: Health Canada
March 2024
Req # A-2023-001123
With respect to the Pfizer report entitled 125742_S1_M5_5351_c4591001-interim-mth6-adverse-events, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified…Organization: Health Canada
March 2024